MREO — Mereo BioPharma Balance Sheet
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall Cap
- $97.02m
- $88.78m
- £36.46m
Annual balance sheet for Mereo BioPharma, fiscal year end - December 31st, millions except per share.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | 20-F | |
| Standards: | — | IFRS | IFRS | IFRS |
| Status: | fx Preliminary | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | — | 16.3 | 23.5 | 94.3 |
| Net Total Receivables | — | 12 | 4.64 | 2.23 |
| Prepaid Expenses | ||||
| Total Current Assets | — | 30.4 | 29.7 | 99.3 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | — | 11.6 | 1.57 | 2.53 |
| Net Intangible Assets | ||||
| Total Assets | — | 86.4 | 62.9 | 126 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | — | 29.9 | 8.56 | 12.5 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | — | 46.2 | 77.9 | 38.4 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| ESOP Debt Guarantee | ||||
| Other Equity | ||||
| Total Equity | — | 40.3 | -15 | 88 |
| Total Liabilities & Shareholders' Equity | — | 86.4 | 62.9 | 126 |
| Total Common Shares Outstanding |